Mayo Clinic Laboratories > Oncology > Sarcoma > Next-generation sequencing

Next-generation sequencing

Comprehensive genetic testing to guide patient care

With numerous types of sarcomas that can have overlapping features, diagnosis can be challenging. Using only histological and immunophenotypic features can lead to a high rate of inaccurate diagnoses. Genetic testing can improve diagnostic accuracy and overall patient management.

Next-generation sequencing test menu

Next-generation sequencing panels

Mayo Clinic Laboratories’ comprehensive, next-generation sequencing sarcoma fusion panel includes 169 genes and assesses mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors. Because fusion events can occur between known or novel gene partners, the panel is designed to provide the most comprehensive analysis by including 124 gene fusion pairs, 274 fusion variants, and novel gene partner detection.

Key testing

Additional testing


Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.